BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Villanueva C, López-balaguer JM, Aracil C, Kolle L, González B, Miñana J, Soriano G, Guarner C, Balanzó J. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. Journal of Hepatology 2004;40:757-65. [DOI: 10.1016/j.jhep.2004.01.017] [Cited by in Crossref: 124] [Cited by in F6Publishing: 100] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Villanueva C, Graupera I, Aracil C, Alvarado E, Miñana J, Puente Á, Hernandez-Gea V, Ardevol A, Pavel O, Colomo A, Concepción M, Poca M, Torras X, Reñe JM, Guarner C. A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis. Hepatology 2017;65:1693-707. [PMID: 28100019 DOI: 10.1002/hep.29056] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 10.5] [Reference Citation Analysis]
2 Parikh S. Hepatic Venous Pressure Gradient: Worth Another Look? Dig Dis Sci. 2009;54:1178-1183. [PMID: 18975087 DOI: 10.1007/s10620-008-0491-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
3 Merli M, Lucidi C, Di Gregorio V, Giannelli V, Giusto M, Ceccarelli G, Riggio O, Venditti M. The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis. Liver Int. 2015;35:362-369. [PMID: 24836902 DOI: 10.1111/liv.12593] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 9.3] [Reference Citation Analysis]
4 Kim MY, Jeong WK, Baik SK. Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol 2014; 20(15): 4300-4315 [PMID: 24764667 DOI: 10.3748/wjg.v20.i15.4300] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 57] [Article Influence: 9.3] [Reference Citation Analysis]
5 Vorobioff JD, Groszmann RJ. Hepatic venous pressure gradient measurement in pre-primary and primary prophylaxis of variceal hemorrhage. Annals of Hepatology 2013;12:22-9. [DOI: 10.1016/s1665-2681(19)31381-x] [Cited by in Crossref: 12] [Article Influence: 1.5] [Reference Citation Analysis]
6 Burroughs AK, Thalheimer U. Hepatic venous pressure gradient in 2010: optimal measurement is key. Hepatology. 2010;51:1894-1896. [PMID: 20512984 DOI: 10.1002/hep.23710] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
7 Veldhuijzen van Zanten D, Buganza E, Abraldes JG. The Role of Hepatic Venous Pressure Gradient in the Management of Cirrhosis. Clin Liver Dis 2021;25:327-43. [PMID: 33838853 DOI: 10.1016/j.cld.2021.01.002] [Reference Citation Analysis]
8 De BK, Dutta D, Som R, Biswas PK, Pal SK, Biswas A. Hemodynamic effects of propranolol with spironolactone in patients with variceal bleeds: A randomized controlled trial. World J Gastroenterol 2008; 14(12): 1908-1913 [PMID: 18350631 DOI: 10.3748/wjg.14.1908] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
9 Xu X, Guo X, Tacke F, Shao X, Qi X. Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence. Ther Adv Chronic Dis 2019;10:2040622319862693. [PMID: 31321015 DOI: 10.1177/2040622319862693] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009;6:573-82. [PMID: 19724251 DOI: 10.1038/nrgastro.2009.149] [Cited by in Crossref: 363] [Cited by in F6Publishing: 309] [Article Influence: 30.3] [Reference Citation Analysis]
11 Madsen BS, Havelund T, Krag A. Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers. Adv Ther 2013;30:659-70. [PMID: 23881723 DOI: 10.1007/s12325-013-0044-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
12 Fortea JI, Puente Á, Ruiz P, Ezcurra I, Vaquero J, Cuadrado A, Arias-Loste MT, Cabezas J, Llerena S, Iruzubieta P, Rodríguez-Lope C, Huelin P, Casafont F, Fábrega E, Crespo J. Impact of an acute hemodynamic response-guided protocol for primary prophylaxis of variceal bleeding. World J Clin Cases 2018; 6(13): 611-623 [PMID: 30430116 DOI: 10.12998/wjcc.v6.i13.611] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Thalheimer U, Bosch J, Burroughs AK. How to prevent varices from bleeding: shades of grey--the case for nonselective beta blockers. Gastroenterology. 2007;133:2029-2036. [PMID: 18054573 DOI: 10.1053/j.gastro.2007.10.028] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
14 Hernández-Guerra M, García-Pagán JC, Bosch J. Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension. J Clin Gastroenterol 2005;39:S131-7. [PMID: 15758648 DOI: 10.1097/01.mcg.0000155513.17715.f7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
15 Triantos C, Goulis J, Burroughs AK. Portal Hypertensive Bleeding. In: Mcdonald JW, Burroughs AK, Feagan BG, Fennerty MB, editors. Evidence‐Based Gastroenterology and Hepatology. Wiley; 2010. pp. 562-602. [DOI: 10.1002/9781444314403.ch36] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Mustafa MZ, Stanley A. Variceal rebleeding: use of drug therapy and endoscopic band ligation. Expert Review of Gastroenterology & Hepatology 2013;8:179-83. [DOI: 10.1586/17474124.2014.876358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Mallet M, Rudler M, Thabut D. Variceal bleeding in cirrhotic patients. Gastroenterol Rep (Oxf). 2017;5:185-192. [PMID: 28852523 DOI: 10.1093/gastro/gox024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
18 Augustin S, González A, Badia L, Millán L, Gelabert A, Romero A, Segarra A, Martell M, Esteban R, Guardia J, Genescà J. Long-term follow-up of hemodynamic responders to pharmacological therapy after variceal bleeding. Hepatology 2012;56:706-14. [DOI: 10.1002/hep.25686] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
19 López-Méndez E, Uribe M. Beta blockers in portal hypertension. Are they really a good option? Ann Hepatol 2006;5:86-91. [PMID: 16807514 [PMID: 16807514 DOI: 10.1016/s1665-2681(19)32023-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Merkel C, Bolognesi M, Berzigotti A, Amodio P, Cavasin L, Casarotto IM, Zoli M, Gatta A. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria. J Hepatol. 2010;52:45-53. [PMID: 19914730 DOI: 10.1016/j.jhep.2009.10.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
21 Pfisterer N, Dexheimer C, Fuchs EM, Bucsics T, Schwabl P, Mandorfer M, Gessl I, Sandrieser L, Baumann L, Riedl F, Scheiner B, Pachofszky T, Dolak W, Schrutka-Kölbl C, Ferlitsch A, Schöniger-Hekele M, Peck-Radosavljevic M, Trauner M, Madl C, Reiberger T. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding. Aliment Pharmacol Ther 2018;47:966-79. [PMID: 29388229 DOI: 10.1111/apt.14485] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
22 Thalheimer U, Christie J, Burroughs AK. Benefits of Beta blockade beyond bleeding prophylaxis and the role of adherence. Am J Gastroenterol 2012;107:1593. [PMID: 23034623 DOI: 10.1038/ajg.2012.261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
23 Garcia-tsao G. Portal hypertension: . Current Opinion in Gastroenterology 2005;21:313-22. [DOI: 10.1097/01.mog.0000158110.13722.e0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
24 Reiberger T, Bucsics T, Paternostro R, Pfisterer N, Riedl F, Mandorfer M. Small Esophageal Varices in Patients with Cirrhosis-Should We Treat Them? Curr Hepatol Rep. 2018;17:301-315. [PMID: 30546995 DOI: 10.1007/s11901-018-0420-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
25 Muntaner L, Altamirano JT, Augustin S, González A, Esteban R, Guardia J, Genescà J. High doses of beta-blockers and alcohol abstinence improve long-term rebleeding and mortality in cirrhotic patients after an acute variceal bleeding. Liver Int. 2010;30:1123-1130. [PMID: 20536715 DOI: 10.1111/j.1478-3231.2010.02287.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
26 de-Madaria E, Palazón JM, Hernández FT, Sánchez-Paya J, Zapater P, Irurzun J, de España F, Pascual S, Such J, Sempere L, Carnicer F, García-Herola A, Valverde J, Pérez-Mateo M. Acute and chronic hemodynamic changes after propranolol in patients with cirrhosis under primary and secondary prophylaxis of variceal bleeding: a pilot study. Eur J Gastroenterol Hepatol 2010;22:507-12. [PMID: 20150817 DOI: 10.1097/MEG.0b013e32832ca06b] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
27 Bruha R, Vitek L, Petrtyl J, Lenicek M, Urbanek P, Zelenka J, Jachymova M, Svestka T, Kalab M, Dousa M, Marecek Z. Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes. Scandinavian Journal of Gastroenterology 2009;41:1454-63. [DOI: 10.1080/00365520600780403] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
28 Superina RA, Alonso EM. Medical and surgical management of portal hypertension in children. Curr Treat Options Gastro 2006;9:432-43. [DOI: 10.1007/bf02738533] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
29 Albillos A, Bañares R, González M, Ripoll C, Gonzalez R, Catalina MV, Molinero LM. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis. Am J Gastroenterol 2007;102:1116-26. [PMID: 17391317 DOI: 10.1111/j.1572-0241.2007.01191.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 74] [Article Influence: 6.9] [Reference Citation Analysis]
30 Turnes J, Garcia-Pagan JC, Abraldes JG, Hernandez-Guerra M, Dell'Era A, Bosch J. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol. 2006;101:506-512. [PMID: 16542287 DOI: 10.1111/j.1572-0241.2006.00453.x] [Cited by in Crossref: 154] [Cited by in F6Publishing: 128] [Article Influence: 10.3] [Reference Citation Analysis]
31 Jang YJ, Kim KW, Jeong WK, Shin YM, Song GW, Hwang S, Lee SG. Influence of preoperative portal hypertension and graft size on portal blood flow velocity in recipient after living donor liver transplantation with right-lobe graft. AJR Am J Roentgenol 2010;194:W165-70. [PMID: 20093568 DOI: 10.2214/AJR.09.2591] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
32 Wolf AT, Maurer R, Glickman J, Grace ND. Hepatic venous pressure gradient supplements liver biopsy in the diagnosis of cirrhosis. J Clin Gastroenterol 2008;42:199-203. [PMID: 18209592 DOI: 10.1097/01.mcg.0000225681.45088.48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
33 Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J; Portal Hypertension Collaborative Group. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133:481-488. [PMID: 17681169 DOI: 10.1053/j.gastro.2007.05.024] [Cited by in Crossref: 643] [Cited by in F6Publishing: 519] [Article Influence: 45.9] [Reference Citation Analysis]
34 Magaz M, Baiges A, Hernández-Gea V. Precision medicine in variceal bleeding: Are we there yet? J Hepatol. 2020;72:774-784. [PMID: 31981725 DOI: 10.1016/j.jhep.2020.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
35 Guo H, Xiao J, Wang Y, Zhang M, Zhuge Y, Zhang F. Increase in Free Hepatic Venous Pressure Response to Beta-Blockers Predicts Variceal Bleeding in Cirrhotic Patients. Biomed Res Int 2021;2021:5587566. [PMID: 33997022 DOI: 10.1155/2021/5587566] [Reference Citation Analysis]
36 Garcia-Pagan JC, De Gottardi A, Bosch J. Review article: the modern management of portal hypertension--primary and secondary prophylaxis of variceal bleeding in cirrhotic patients. Aliment Pharmacol Ther. 2008;28:178-186. [PMID: 18462268 DOI: 10.1111/j.1365-2036.2008.03729.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
37 Ikenaga N, Liu SB, Sverdlov DY, Yoshida S, Nasser I, Ke Q, Kang PM, Popov Y. A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer. Am J Pathol 2015;185:325-34. [PMID: 25478810 DOI: 10.1016/j.ajpath.2014.10.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
38 Turnes J, Hernández-Guerra M, Abraldes JG, Bellot P, Oliva R, García-Pagán JC, Bosch J. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis. Hepatology. 2006;43:34-41. [PMID: 16374847 DOI: 10.1002/hep.21000] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
39 Hernández-gea V, Aracil C, Colomo A, Garupera I, Poca M, Torras X, Miñana J, Guarner C, Villanueva C. Development of Ascites in Compensated Cirrhosis With Severe Portal Hypertension Treated With β-Blockers. American Journal of Gastroenterology 2012;107:418-27. [DOI: 10.1038/ajg.2011.456] [Cited by in Crossref: 87] [Cited by in F6Publishing: 65] [Article Influence: 9.7] [Reference Citation Analysis]
40 Jachs M, Reiberger T. Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach. Clin Liver Dis 2021;25:311-26. [PMID: 33838852 DOI: 10.1016/j.cld.2021.01.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Dittrich S, Mattos AA, Mattos AZ, Alves AV, Araújo FB. [Relationship between portal pressure gradient and ascites in cirrhotic patients]. Arq Gastroenterol. 2010;47:174-177. [PMID: 20721463 DOI: 10.1590/S0004-28032010000200011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Triantos CK, Nikolopoulou V, Burroughs AK. Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis. Aliment Pharmacol Ther. 2008;28:943-952. [PMID: 18627364 DOI: 10.1111/j.1365-2036.2008.03798.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
43 Sharma B, Sarin S. Hepatic Venous Pressure Gradient in Cirrhosis: Role in Variceal Bleeding, Non-bleeding Complications and Outcome. Asian Journal of Surgery 2006;29:113-9. [DOI: 10.1016/s1015-9584(09)60068-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Senzolo M, Burra P, Cholongitas E, Lodato F, Marelli L, Manousou P, Patch D, Sturniolo GC, Burroughs AK. The transjugular route: the key hole to the liver world. Dig Liver Dis. 2007;39:105-116. [PMID: 17196894 DOI: 10.1016/j.dld.2006.06.038] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
45 Abraldes JG, Villanueva C, Aracil C, Turnes J, Hernandez-guerra M, Genesca J, Rodriguez M, Castellote J, García-pagán JC, Torres F, Calleja JL, Albillos A, Bosch J, Augustin S, Llop E, Arraez DM, Hernández Mesa G, Martinez J, Reverter E, Seijo S, Turon F, Miñana J, Buenestado J, Reñe JM, Navacués CA, Planas R, Morillas RM, Bellot P, Such J, Vergara M, Puente A, de la Pena J, Mera Calviño J, Rivas Moral L, Pavel O, Alvarado E, Ardevol A, Girbau A, Cachero A, Arnaiz JA, Berzigotti A, Pich J, Rios J, Saenz R, Millan L, Beleta H, Ramos N. Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis. Gastroenterology 2016;150:1160-1170.e3. [DOI: 10.1053/j.gastro.2016.01.004] [Cited by in Crossref: 143] [Cited by in F6Publishing: 115] [Article Influence: 28.6] [Reference Citation Analysis]
46 Rincón D, Lo Iacono O, Tejedor M, Hernando A, Ripoll C, Catalina MV, Salcedo M, Matilla A, Senosiain M, Clemente G. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis. Scand J Gastroenterol. 2013;48:487-495. [PMID: 22871085 DOI: 10.3109/00365521.2012.711848] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
47 González A, Augustin S, Pérez M, Dot J, Saperas E, Tomasello A, Segarra A, Armengol JR, Malagelada JR, Esteban R, Guardia J, Genescà J. Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study. Hepatology 2006;44:806-12. [PMID: 17006916 DOI: 10.1002/hep.21343] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
48 Mandorfer M, Simbrunner B. Prevention of First Decompensation in Advanced Chronic Liver Disease. Clin Liver Dis 2021;25:291-310. [PMID: 33838851 DOI: 10.1016/j.cld.2021.01.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Heebøll S, Villadsen GE, Aagaard NK, Grønbæk H, Vilstrup H, Keiding S. Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience. Scand J Gastroenterol. 2013;48:969-973. [PMID: 23755897 DOI: 10.3109/00365521.2013.805811] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
50 Tandon P, Ripoll C, Assis D, Wongcharatrawee S, Groszmann RJ, Garcia-Tsao G. The interpretation of hepatic venous pressure gradient tracings - excellent interobserver agreement unrelated to experience. Liver Int 2016;36:1160-6. [PMID: 26763558 DOI: 10.1111/liv.13065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
51 Burroughs AK. The Hepatic Artery, Portal Venous System and Portal Hypertension: The Hepatic Veins and Liver in Circulatory Failure. In: Dooley JS, Lok ASF, Burroughs AK, Heathcote EJ, editors. Sherlock's Diseases of the Liver and Biliary System. Oxford: Wiley-Blackwell; 2011. pp. 152-209. [DOI: 10.1002/9781444341294.ch9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
52 Huang L, Yu Q, Wang J. Association Between Changes in Splanchnic Hemodynamics and Risk Factors of Portal Venous System Thrombosis After Splenectomy with Periesophagogastric Devascularization. Med Sci Monit 2018;24:4355-62. [PMID: 29937539 DOI: 10.12659/MSM.909403] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
53 Villanueva C, Colomo A, Aracil C, Guarner C. Current endoscopic therapy of variceal bleeding. Best Pract Res Clin Gastroenterol. 2008;22:261-278. [PMID: 18346683 DOI: 10.1016/j.bpg.2007.11.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
54 Manolakopoulos S, Triantos C, Theodoropoulos J, Vlachogiannakos J, Kougioumtzan A, Papatheodoridis G, Tzourmakliotis D, Karamanolis D, Burroughs AK, Archimandritis A. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension. J Hepatol. 2009;51:468-474. [PMID: 19616339 DOI: 10.1016/j.jhep.2009.05.031] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 5.3] [Reference Citation Analysis]
55 Turco L, Villanueva C, La Mura V, García-pagán JC, Reiberger T, Genescà J, Groszmann RJ, Sharma BC, Merkel C, Bureau C, Alvarado E, Abraldes JG, Albillos A, Bañares R, Peck-radosavljevic M, Augustin S, Sarin SK, Bosch J, García-tsao G. Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis. Clinical Gastroenterology and Hepatology 2020;18:313-327.e6. [DOI: 10.1016/j.cgh.2019.05.050] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 22.0] [Reference Citation Analysis]
56 La Mura V, Garcia‐guix M, Berzigotti A, Abraldes JG, García‐pagán JC, Villanueva C, Bosch J. A Prognostic Strategy Based on Stage of Cirrhosis and HVPG to Improve Risk Stratification After Variceal Bleeding. Hepatology 2020;72:1353-65. [DOI: 10.1002/hep.31125] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
57 Puente A, Hernández-gea V, Graupera I, Roque M, Colomo A, Poca M, Aracil C, Gich I, Guarner C, Villanueva C. Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review. Liver Int 2014;34:823-33. [DOI: 10.1111/liv.12452] [Cited by in Crossref: 68] [Cited by in F6Publishing: 47] [Article Influence: 9.7] [Reference Citation Analysis]
58 Villanueva C, Aracil C, Colomo A, Hernández-Gea V, López-Balaguer JM, Alvarez-Urturi C, Torras X, Balanzó J, Guarner C. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology. 2009;137:119-128. [PMID: 19344721 DOI: 10.1053/j.gastro.2009.03.048] [Cited by in Crossref: 140] [Cited by in F6Publishing: 107] [Article Influence: 11.7] [Reference Citation Analysis]
59 Mandorfer M, Hernández-gea V, Reiberger T, García-pagán JC. Hepatic Venous Pressure Gradient Response in Non-Selective Beta-Blocker Treatment—Is It Worth Measuring? Curr Hepatology Rep 2019;18:174-86. [DOI: 10.1007/s11901-019-00469-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
60 D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology. 2006;131:1611-1624. [PMID: 17101332 DOI: 10.1053/j.gastro.2006.09.013] [Cited by in Crossref: 333] [Cited by in F6Publishing: 260] [Article Influence: 22.2] [Reference Citation Analysis]
61 Boyer TD. Wedged hepatic vein pressure (WHVP): ready for prime time. Hepatology 2006;43:405-6. [PMID: 16496346 DOI: 10.1002/hep.21118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
62 Abraldes JG, Sarlieve P, Tandon P. Measurement of portal pressure. Clin Liver Dis. 2014;18:779-792. [PMID: 25438283 DOI: 10.1016/j.cld.2014.07.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
63 Bosch J, Abraldes JG. Variceal bleeding: pharmacological therapy. Dig Dis 2005;23:18-29. [PMID: 15920322 DOI: 10.1159/000084722] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
64 Kerbert AJ, Chiang FW, van der Werf M, Stijnen T, Slingerland H, Verspaget HW, van Hoek B, Coenraad MJ. Hemodynamic response to primary prophylactic therapy with nonselective β-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysis. Eur J Gastroenterol Hepatol 2017;29:380-7. [PMID: 28002118 DOI: 10.1097/MEG.0000000000000812] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
65 Burroughs AK, Triantos CK. Predicting failure to control bleeding and mortality in acute variceal bleeding. J Hepatol. 2008;48:185-188. [PMID: 18155797 DOI: 10.1016/j.jhep.2007.11.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
66 Burroughs AK, Tsochatzis EA, Triantos C. Primary prevention of variceal haemorrhage: a pharmacological approach. J Hepatol. 2010;52:946-948. [PMID: 20400198 DOI: 10.1016/j.jhep.2010.02.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
67 Bittencourt PL, Farias AQ, Strauss E, Mattos AA; Pannel of the 1st Brazilian Consensus of Variceal Bleeding, Brazilian Society of Hepatology. Variceal bleeding: consensus meeting report from the Brazilian Society of Hepatology. Arq Gastroenterol. 2010;47:202-216. [PMID: 20721469 DOI: 10.1590/s0004-28032010000200017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
68 Groszmann R, Vorobioff JD, Gao H. Measurement of portal pressure: when, how, and why to do it. Clin Liver Dis 2006;10:499-512, viii. [PMID: 17162225 DOI: 10.1016/j.cld.2006.08.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
69 Triantos CK, Burroughs AK. Prevention of the development of varices and first portal hypertensive bleeding episode. Best Pract Res Clin Gastroenterol. 2007;21:31-42. [PMID: 17223495 DOI: 10.1016/j.bpg.2006.06.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
70 Reiberger T, Mandorfer M. Beta adrenergic blockade and decompensated cirrhosis. J Hepatol. 2017;66:849-859. [PMID: 27864004 DOI: 10.1016/j.jhep.2016.11.001] [Cited by in Crossref: 74] [Cited by in F6Publishing: 53] [Article Influence: 14.8] [Reference Citation Analysis]
71 Triantos C, Samonakis D, Thalheimer U, Patch D, Burroughs A. The relationship between liver function and portal pressure: what comes first, the chicken or the egg? Journal of Hepatology 2005;42:146-7. [DOI: 10.1016/j.jhep.2004.07.023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
72 Kreisel W, Schaffner D, Lazaro A, Trebicka J, Merfort I, Schmitt-Graeff A, Deibert P. Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension. Int J Mol Sci 2020;21:E6223. [PMID: 32872119 DOI: 10.3390/ijms21176223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
73 Bureau C, Metivier S, Peron JM, Selves J, Robic MA, Gourraud PA, Rouquet O, Dupuis E, Alric L, Vinel JP. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther. 2008;27:1261-1268. [PMID: 18397389 DOI: 10.1111/j.1365-2036.2008.03701.x] [Cited by in Crossref: 255] [Cited by in F6Publishing: 231] [Article Influence: 19.6] [Reference Citation Analysis]
74 Kotani K, Uchida-Kobayashi S, Yamamoto A, Kawamura E, Enomoto M, Higashiyama S, Kawabe J, Shiomi S, Tamori A, Kawada N. Per-rectal portal scintigraphy as an alternative measure of hepatic venous pressure gradient in chronic liver disease: A preliminary report. Clin Physiol Funct Imaging 2021;41:334-41. [PMID: 33843126 DOI: 10.1111/cpf.12703] [Reference Citation Analysis]
75 Merkel C, Montagnese S. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes! Eur J Intern Med 2011;22:1-4. [PMID: 21238883 DOI: 10.1016/j.ejim.2010.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
76 Ripoll C. Hepatic venous pressure gradient and outcomes in cirrhosis. J Clin Gastroenterol. 2007;41 Suppl 3:S330-S335. [PMID: 17975485 DOI: 10.1097/mcg.0b013e318150d0f4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
77 Englesbe MJ, Kubus J, Muhammad W, Sonnenday CJ, Welling T, Punch JD, Lynch RJ, Marrero JA, Pelletier SJ. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl. 2010;16:83-90. [PMID: 20035521 DOI: 10.1002/lt.21941] [Cited by in Crossref: 146] [Cited by in F6Publishing: 131] [Article Influence: 13.3] [Reference Citation Analysis]
78 Bochnakova T. Hepatic Venous Pressure Gradient. Clin Liver Dis (Hoboken) 2021;17:144-8. [PMID: 33868655 DOI: 10.1002/cld.1031] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
79 Merkel C, Montagnese S. Hepatic venous pressure gradient measurement in clinical hepatology. Dig Liver Dis 2011;43:762-7. [PMID: 21549649 DOI: 10.1016/j.dld.2011.03.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
80 Thalheimer U, Leandro G, Samonakis DN, Triantos CK, Patch D, Burroughs AK. Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients. Dig Liver Dis. 2005;37:601-608. [PMID: 15908290 DOI: 10.1016/j.dld.2005.02.009] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 4.1] [Reference Citation Analysis]
81 Spahr L, Goossens N, Furrer F, Dupuis M, Vijgen S, Elkrief L, Giostra E, Rubbia-Brandt L, Frossard JL. A return to harmful alcohol consumption impacts on portal hemodynamic changes following alcoholic hepatitis. Eur J Gastroenterol Hepatol 2018;30:967-74. [PMID: 29727387 DOI: 10.1097/MEG.0000000000001148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Dib N, Konate A, Oberti F, Calès P. [Non-invasive diagnosis of portal hypertension in cirrhosis. Application to the primary prevention of varices]. Gastroenterol Clin Biol 2005;29:975-87. [PMID: 16435503 DOI: 10.1016/s0399-8320(05)88170-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
83 Villanueva C, Aracil C, Balanzó J. What to do with non-responders. In: Groszmann RJ, Bosch J, editors. Portal Hypertension in the 21st Century. Dordrecht: Springer Netherlands; 2004. pp. 337-48. [DOI: 10.1007/978-94-007-1042-9_34] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
84 Vorobioff JD. Hepatic venous pressure in practice: how, when, and why. J Clin Gastroenterol 2007;41 Suppl 3:S336-43. [PMID: 17975486 DOI: 10.1097/MCG.0b013e31814684d3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
85 Fede G, D'Amico G, Arvaniti V, Tsochatzis E, Germani G, Georgiadis D, Morabito A, Burroughs AK. Renal failure and cirrhosis: a systematic review of mortality and prognosis. J Hepatol. 2012;56:810-818. [PMID: 22173162 DOI: 10.1016/j.jhep.2011.10.016] [Cited by in Crossref: 158] [Cited by in F6Publishing: 139] [Article Influence: 15.8] [Reference Citation Analysis]
86 Groszmann RJ, Ripoll C, Vorobioff J. Pre-Primary and Primary Prophylaxis: What Should We Do Next? In: de Franchis R, editor. Portal Hypertension V. Oxford: Wiley-Blackwell; 2011. pp. 66-74. [DOI: 10.1002/9781444393989.ch7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 Miñano C, Garcia-Tsao G. Clinical pharmacology of portal hypertension. Gastroenterol Clin North Am 2010;39:681-95. [PMID: 20951924 DOI: 10.1016/j.gtc.2010.08.015] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
88 Abraldes JG, Angermayr B, Bosch J. The management of portal hypertension. Clin Liver Dis 2005;9:685-713, vii. [PMID: 16207571 DOI: 10.1016/j.cld.2005.08.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
89 Silva-junior G, Turon F, Baiges A, Cerda E, García-criado Á, Blasi A, Torres F, Hernandez-gea V, Bosch J, Garcia-pagan JC. Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension. Gastroenterology 2017;152:1358-65. [DOI: 10.1053/j.gastro.2017.01.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
90 Villanueva C, Aracil C, Colomo A, Lopez-Balaguer JM, Piqueras M, Gonzalez B, Torras X, Guarner C, Balanzo J. Clinical trial: A randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy. Aliment Pharmacol Ther. 2009;29:397-408. [PMID: 19006538 DOI: 10.1111/j.1365-2036.2008.03880.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
91 Bellot P, García-Pagán JC, Abraldes JG, Bosch J. Primary prophylaxis of esophageal variceal bleeding in cirrhosis. Gastroenterol Clin Biol. 2008;32:532-540. [PMID: 18456445 DOI: 10.1016/j.gcb.2008.03.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
92 Kimer N, Feineis M, Møller S, Bendtsen F. Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature. Scand J Gastroenterol. 2015;50:129-137. [PMID: 25113796 DOI: 10.3109/00365521.2014.948053] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
93 Lopez-mendez E, Avila-escobedo L. Pregnancy and portal hypertension a pathology view of physiologic changes. Annals of Hepatology 2006;5:219-23. [DOI: 10.1016/s1665-2681(19)32016-2] [Cited by in Crossref: 12] [Article Influence: 0.8] [Reference Citation Analysis]
94 Villanueva C, Balanzó J. Variceal Bleeding: Pharmacological Treatment and Prophylactic Strategies. Drugs 2008;68:2303-24. [DOI: 10.2165/0003495-200868160-00004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
95 Lo GH, Chen WC, Lin CK, Tsai WL, Chan HH, Chen TA, Yu HC, Hsu PI, Lai KH. Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding. Hepatology. 2008;48:580-587. [PMID: 18666235 DOI: 10.1002/hep.22358] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 5.7] [Reference Citation Analysis]
96 Bosch J, Abraldes JG, Albillos A, Aracil C, Bañares R, Berzigotti A, Calleja JL, de la Peña J, Escorsell A, García-pagán JC, Genescà J, Hernández-guerra M, Ripoll C, Planas R, Villanueva C. Hipertensión portal: recomendaciones para su evaluación y tratamiento. Gastroenterología y Hepatología 2012;35:421-50. [DOI: 10.1016/j.gastrohep.2012.02.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
97 Shimizu T, Shun A, Thomas G. Portosystemic shunt for portal hypertension after Kasai operation in patients with biliary atresia. Pediatr Surg Int 2021;37:101-7. [PMID: 33201302 DOI: 10.1007/s00383-020-04773-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Thalheimer U, Bellis L, Puoti C, Burroughs AK. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No. Eur J Intern Med 2011;22:5-7. [PMID: 21238884 DOI: 10.1016/j.ejim.2010.12.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
99 Poza Cordon J, Froilan Torres C, Burgos García A, Gea Rodriguez F, Suárez de Parga JM. Endoscopic management of esophageal varices. Clinical manifestations and management 2012; 4(7): 312-322 [PMID: 22816012 DOI: 10.4253/wjge.v4.i7.312] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]